B. Balbi (Veruno (NO), Italy), L. Degani-Costa (São Paulo (SP), Brazil)
Late Breaking Abstract - Silent exacerbations: underreporting of COPD exacerbations in Poland
M. Farnik (Katowice, Poland), D. Brzostek (Warszawa, Poland)
|   |
Late Breaking Abstract - Burden of pertussis in COPD: a retrospective database study in England
E. ARIS (Wavre, Belgium), E. Akpo (Wavre, Belgium), A. Bhavsar (Wavre, Belgium), L. Harrington (Wavre, Belgium), E. Merinopoulou (London, United Kingdom), N. Sawalhi-Leckenby (London, United Kingdom), E. Turriani (Wavre, Belgium), K. Meszaros (Wavre, Belgium), D. Lambrelli (London, United Kingdom), P. Mukherjee (Wavre, Belgium)
| |
Late Breaking Abstract - Compare outcomes between COPD patients treated with Tiotropium/Olodaterol (TIO/OLO) and other fixed-dose LAMA/LABAs
S. Palli (Ridgefield, United States of America), C. Elliott (Eden Prairie, United States of America), B. Xie (Eden Prairie, United States of America), B. Chastek (Eden Prairie, United States of America), L. Bengston (Eden Prairie, United States of America)
| |
Clinical features of eosinophilic COPD
B. Arpinar Yigitbas (Istanbul, Germany), B. Uslu (Istanbul, Germany), A. Gülsen (Lübeck, Germany)
| |
Role of interleukin 6 in COPD patients over nine years
R. Prudente (Botucatu, Brazil), C. Mesquita (Botucatu, Brazil), E. Franco (Botucatu, Brazil), R. Ferrari (Botucatu, Brazil), I. Godoy (Botucatu, Brazil), S. Tanni (Botucatu, Brazil)
| |
Transforming growth factor beta 1 (TGF-ß1) level as a marker of COPD severity
T. Pertseva (Dnipropetrovsk, Ukraine), D. Koval (Dnipropetrovsk, Ukraine)
| |
Prevention of COPD exacerbations using nebulization with an electrolytic silver solution
A. Lobanov (Moscow, Russian Federation), S. Andronov (Moscow, Russian Federation), E. Bogdanova (Severodvinsk, Russian Federation), A. Emelyanov (Saint-Petersburg, Russian Federation), A. Fesyun (Moscow, Russian Federation), A. Rachin (Moscow, Russian Federation), G. Barashkov (Moscow, Russian Federation), A. Nikitina (Moscow, Russian Federation), A. Popov (Nadym, Russian Federation)
| |
Factors associated with exacerbations in patients with COPD: NOVELTY study
H. Müllerová (Cambridge, United Kingdom), B. Ding (Gothenburg, Sweden), E. Rapsomaniki (Cambridge, United Kingdom), R. Beasley (Wellington, New Zealand), J. Fitzgerald (Vancouver, Canada), T. Harrison (Nottingham, United Kingdom), R. Hughes (Cambridge, United Kingdom), J. Olaguibel (Pamplona, Spain), H. Reddel (Sydney, Australia), P. Varghese (Gaithersburg, MD, United States of America), M. Sadatsafavi (Vancouver, Canada), C. Janson (Uppsala, Sweden)
| |
Effect of Multiple Comorbidities on Mortality in COPD
W. Cho (SEOUL, Republic of Korea), Y. Kim (SEOUL, Republic of Korea), Y. Kim (SEOUL, Republic of Korea)
| |
Skeletal muscle dysfunction among COPD patients in Eastern Europe
V. Poberezhets (Vinnytsya, Ukraine), S. Skoczynski (Katowice, Poland), A. Demchuk (Vinnytsya, Ukraine), A. Oraczewska (Katowice, Poland), E. Tobiczyk (Poznan, Poland), Y. Mostovoy (Vinnytsya, Ukraine), A. Barczyk (Katowice, Poland)
| |
Characteristics of patients with homogeneous and heterogeneous emphysema
M. Bakeer (Mansoura, Egypt), . Duller (Vienna, Austria), K. Groß (Vienna, Austria), G. Funk (Vienna, Austria), A. Valipour (Vienna, Austria)
| |
Influence of coexistent Chronic Obstructive Pulmonary Disease in Heart Failure on linear and nonlinear dynamics of Heart Rate Variability
M. OLIVEIRA (São Carlos, Brazil), C. Goulart (São Carlos, Brazil), G. Peixoto (São Carlos, Brazil), P. Santos (São Carlos, Brazil), P. Camargo (São Carlos, Brazil), R. Mendes (São Carlos, Brazil), F. Caruso (São Carlos, Brazil), A. Borghi-Silva (São Carlos, Brazil)
| |
Early signs of COPD in 42 years old individuals with severe alpha-1-antitrypsin deficiency
G. Schramm (Malmö, Sweden), E. Piitulainen (Malmö, Sweden), P. Wollmer (Malmö, Sweden), H. Tanash (Malmö, Sweden)
| |
COPD burden on sexual well-being
J. Rubenstein (Pessac, France), M. Zysman (Pessac, France), F. Le Guillou (Paris, France), M. Colson (Marseille, France), C. Pochulu (Paris, France), L. Grassion (Pessac, France), R. Escamilla (Toulouse, France), D. Piperno (Paris, France), J. Pon (Toulouse, France), C. Raherison-Semjen (Bordeaux, France)
| |
Diagnostic value of N-terminal pro-brain natriuretic peptide in patients with COPD with chronic hypoxemic respiratory failure.
O. Titova (St. Petersburg, Russian Federation), N. Kuzubova (St. Petersburg, Russian Federation), D. Sklyarova (St. Petersburg, Russian Federation), V. Volchkov (St. Petersburg, Russian Federation), E. Volchkova (St. Petersburg, Russian Federation)
| |
Association between right heart failure and endothelial dysfunction in COPD patients
Y. Gastelum Ayala (CDMX, Mexico), R. Sanchez Santillan (CDMX, Mexico), A. Orea Tejeda (CDMX, Mexico), D. Gonzalez Islas (CDMX, Mexico), I. Perez Garcia (CDMX, Mexico), O. Martinez Reyna (CDMX, Mexico), N. Martinez Luna (CDMX, Mexico), V. Martinez Vazquez (CDMX, Mexico), M. Quintero Martinez (CDMX, Mexico), S. Cid Juarez (CDMX, Mexico), H. Perea Gutierrez (CDMX, Mexico), S. Montoya Azpeitia (CDMX, Mexico), C. Espinoza De Los Monteros Sanchez (CDMX, Mexico), M. Gomez Martinez (CDMX, Mexico)
| |
DIFFERENCES IN THE QUALITY OF LIFE BETWEEN PATIENTS WITH LEFT HEART FAILURE AND RIGHT HEART FAILURE SECONDARY TO COPD
K. Santillan Reyes (CDMX, Mexico), V. Peláez Hernández (CDMX, Mexico), L. Martínez Bautista (CDMX, Mexico), K. Rosales Castillo (CDMX, Mexico), L. Luna Rodríguez (CDMX, Mexico), A. Orea Tejeda (CDMX, Mexico), O. Reyna Martinez (CDMX, Mexico), M. Gómez Martínez (CDMX, Mexico), V. Martínez Vázquez (CDMX, Mexico)
| |
Are the mMRC dyspnea scale of 2 and a CAT score of 10 equivalent as proposed by the GOLD strategy?
V. Moya Alvarez (Zaragoza, Spain), J. Quevedo Marín (Madrid, Spain), M. Betrán Orduna (Zaragoza, Spain), Z. Ji (Madrid, Spain), M. Fernando Moreno (Zaragoza, Spain), A. Pérez Trullen (Zaragoza, Spain), J. De Miguel-Díez (Madrid, Spain)
| |
Factors affecting survival after severe COPD exacerbations: a single-center experience.
M. Tine (Padova, Italy), G. Turato (Padova, Italy), U. Semenzato (Padova, Italy), E. Bazzan (Padova, Italy), M. Zuffellato (Padova, Italy), K. Lokar-Oliani (Padova, Italy), M. Saetta (Padova, Italy), M. Cosio (Montreal, Canada)
| |
Impact of diabetes in patients with COPD
A. Slim (Tunis, Tunisia), H. Kamoun (Tunis, Tunisia), A. Saidane (Tunis, Tunisia), Y. Hdidène (Tunis, Tunisia), H. Ben Abdelghaffar (Tunis, Tunisia), H. Smadhi (Tunis, Tunisia), D. Greb (Tunis, Tunisia), I. Akrout (Tunis, Tunisia), H. Hassene (Tunis, Tunisia), L. Fekih (Tunis, Tunisia), M. Megdiche (Tunis, Tunisia)
| |